Skip to main content
. 2018 Nov 22;9:2697. doi: 10.3389/fimmu.2018.02697

Figure 1.

Figure 1

PROTAC compounds induce the presentation of MHC-I peptides. (A) PROTAC compounds consist of a protein ligand (triangle) and an E3 ubiquitin-ligase recruiting factor (star). PROTAC compounds induce the proteolytic degradation of target cellular proteins through a ubiquitin-mediated (pink circle) pathway. This could result in the presentation of MHC-I peptides derived from target protein. (B) PROTAC compounds used in this study: all three target the BET family of proteins through the small molecule JQ1 while recruiting different E3 ubiquitin-ligases.